AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00723424
- Locations
- 🇩🇪
Research Site, Berlin, Germany
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
Phase 1
Completed
- Conditions
- Healthy VolunteersPharmacokinetics
- Interventions
- First Posted Date
- 2008-07-28
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT00722956
- Locations
- 🇬🇧
Research Site, London, United Kingdom
An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy
Terminated
- Conditions
- Non-small Cell Lung CancerLung Cancer
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 120
- Registration Number
- NCT00721981
- Locations
- 🇩🇪
Research Site, Trier, Germany
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 7400
- Registration Number
- NCT00722267
- Locations
- 🇬🇧
Research Site, Westbury, United Kingdom
An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Pharmacokinetics
- First Posted Date
- 2008-07-24
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00721448
- Locations
- 🇨🇳
Research Site, Beijing, China
A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 16
- Registration Number
- NCT00720421
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands
Assessment of the Effect of Food on ABT-143 Bioavailability
Phase 1
Completed
- Conditions
- Pharmacokinetic Variables
- Interventions
- Drug: ABT-143 (rosuvastatin calcium and fenofibric acid )
- First Posted Date
- 2008-07-22
- Last Posted Date
- 2012-09-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 115
- Registration Number
- NCT00719693
- Locations
- 🇺🇸
Site Reference ID/Investigator# 9242, Evansville, Indiana, United States
Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.
Completed
- Conditions
- Sprain of Ankle
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2008-09-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6356
- Registration Number
- NCT00717119
- Locations
- 🇪🇸
Research Site, Madrid, Spain
Safety Study of AZD5672 in Renally Impaired Subjects
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2009-04-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 40
- Registration Number
- NCT00715702
- Locations
- 🇩🇪
Research Site, München, Germany
CARE - Quality Improvement in Asthma Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.
Completed
- Conditions
- Asthma
- First Posted Date
- 2008-07-14
- Last Posted Date
- 2011-03-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2122
- Registration Number
- NCT00714038
- Locations
- 🇩🇰
Research Site, Vojens, Denmark
© Copyright 2025. All Rights Reserved by MedPath